Literature DB >> 29545198

Mice Expressing Myc in Neural Precursors Develop Choroid Plexus and Ciliary Body Tumors.

Morgan L Shannon1, Ryann M Fame1, Kevin F Chau2, Neil Dani1, Monica L Calicchio1, Gwenaelle S Géléoc3, Hart G W Lidov1, Sanda Alexandrescu1, Maria K Lehtinen4.   

Abstract

Choroid plexus tumors and ciliary body medulloepithelioma are predominantly pediatric neoplasms. Progress in understanding the pathogenesis of these tumors has been hindered by their rarity and lack of models that faithfully recapitulate the disease. Here, we find that endogenous Myc proto-oncogene protein is down-regulated in the forebrain neuroepithelium, whose neural plate border domains give rise to the anterior choroid plexus and ciliary body. To uncover the consequences of persistent Myc expression, MYC expression was forced in multipotent neural precursors (nestin-Cre:Myc), which produced fully penetrant models of choroid plexus carcinoma and ciliary body medulloepithelioma. Nestin-mediated MYC expression in the epithelial cells of choroid plexus leads to the regionalized formation of choroid plexus carcinoma in the posterior domain of the lateral ventricle choroid plexus and the fourth ventricle choroid plexus that is accompanied by loss of multiple cilia, up-regulation of protein biosynthetic machinery, and hydrocephalus. Parallel MYC expression in the ciliary body leads also to up-regulation of protein biosynthetic machinery. Additionally, Myc expression in human choroid plexus tumors increases with aggressiveness of disease. Collectively, our findings expose a select vulnerability of the neuroepithelial lineage to postnatal tumorigenesis and provide a new mouse model for investigating the pathogenesis of these rare pediatric neoplasms.
Copyright © 2018 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29545198      PMCID: PMC5971223          DOI: 10.1016/j.ajpath.2018.02.009

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

Review 1.  MYC as a regulator of ribosome biogenesis and protein synthesis.

Authors:  Jan van Riggelen; Alper Yetil; Dean W Felsher
Journal:  Nat Rev Cancer       Date:  2010-04       Impact factor: 60.716

Review 2.  Li-Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition.

Authors:  Jessica M Valdez; Kim E Nichols; Chimene Kesserwan
Journal:  Br J Haematol       Date:  2016-12-16       Impact factor: 6.998

3.  Combinatorial regulation of optic cup progenitor cell fate by SOX2 and PAX6.

Authors:  Danielle Matsushima; Whitney Heavner; Larysa H Pevny
Journal:  Development       Date:  2011-02       Impact factor: 6.868

4.  Ciliary body medulloepithelioma: analysis of 41 cases.

Authors:  Swathi Kaliki; Carol L Shields; Ralph C Eagle; Geeta K Vemuganti; Ana Almeida; Fairooz P Manjandavida; Kaustubh Mulay; Santosh G Honavar; Jerry A Shields
Journal:  Ophthalmology       Date:  2013-06-21       Impact factor: 12.079

Review 5.  Medulloblastoma: Molecular Classification-Based Personal Therapeutics.

Authors:  Tenley C Archer; Elizabeth L Mahoney; Scott L Pomeroy
Journal:  Neurotherapeutics       Date:  2017-04       Impact factor: 7.620

6.  TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors.

Authors:  Uri Tabori; Adam Shlien; Berivan Baskin; Sarah Levitt; Peter Ray; Noa Alon; Cynthia Hawkins; Eric Bouffet; Malgorzata Pienkowska; Lucie Lafay-Cousin; Alexa Gozali; Nataliya Zhukova; Lisa Shane; Ignacio Gonzalez; Jonathan Finlay; David Malkin
Journal:  J Clin Oncol       Date:  2010-03-22       Impact factor: 44.544

7.  Prognostic implications of atypical histologic features in choroid plexus papilloma.

Authors:  Astrid Jeibmann; Martin Hasselblatt; Joachim Gerss; Brigitte Wrede; Rupert Egensperger; Rudi Beschorner; Volkmar H J Hans; Christian H Rickert; Johannes E Wolff; Werner Paulus
Journal:  J Neuropathol Exp Neurol       Date:  2006-11       Impact factor: 3.685

8.  Malignant non-teratoid medulloepithelioma of ciliary body with retinoblastic differentiation: a case report and review of literature.

Authors:  Suhail Al-Salam; Kais Algawi; Moueid Alashari
Journal:  Neuropathology       Date:  2008-04-11       Impact factor: 1.906

9.  c-Myc and beta-catenin cooperate with loss of p53 to generate multiple members of the primitive neuroectodermal tumor family in mice.

Authors:  H Momota; A H Shih; M A Edgar; E C Holland
Journal:  Oncogene       Date:  2008-03-31       Impact factor: 9.867

10.  Proto-oncogene c-myc is expressed in cerebellar neurons at different developmental stages.

Authors:  C Ruppert; D Goldowitz; W Wille
Journal:  EMBO J       Date:  1986-08       Impact factor: 11.598

View more
  9 in total

1.  Beta-catenin signaling regulates barrier-specific gene expression in circumventricular organ and ocular vasculatures.

Authors:  Yanshu Wang; Mark F Sabbagh; Xiaowu Gu; Amir Rattner; John Williams; Jeremy Nathans
Journal:  Elife       Date:  2019-04-01       Impact factor: 8.140

2.  Myc and Loss of p53 Cooperate to Drive Formation of Choroid Plexus Carcinoma.

Authors:  Jun Wang; Diana M Merino; Nicholas Light; Brian L Murphy; Yong-Dong Wang; Xiaohui Guo; Andrew P Hodges; Lianne Q Chau; Kun-Wei Liu; Girish Dhall; Shahab Asgharzadeh; Erin N Kiehna; Ryan J Shirey; Kim D Janda; Michael D Taylor; David Malkin; David W Ellison; Scott R VandenBerg; Charles G Eberhart; Rosalie C Sears; Martine F Roussel; Richard J Gilbertson; Robert J Wechsler-Reya
Journal:  Cancer Res       Date:  2019-03-18       Impact factor: 12.701

3.  A concerted metabolic shift in early forebrain alters the CSF proteome and depends on MYC downregulation for mitochondrial maturation.

Authors:  Ryann M Fame; Morgan L Shannon; Kevin F Chau; Joshua P Head; Maria K Lehtinen
Journal:  Development       Date:  2019-10-24       Impact factor: 6.868

Review 4.  Experimental approaches for manipulating choroid plexus epithelial cells.

Authors:  Ahram Jang; Maria K Lehtinen
Journal:  Fluids Barriers CNS       Date:  2022-05-26

5.  A cellular and spatial map of the choroid plexus across brain ventricles and ages.

Authors:  Neil Dani; Rebecca H Herbst; Cristin McCabe; Gilad S Green; Karol Kaiser; Joshua P Head; Jin Cui; Frederick B Shipley; Ahram Jang; Danielle Dionne; Lan Nguyen; Christopher Rodman; Samantha J Riesenfeld; Jan Prochazka; Michaela Prochazkova; Radislav Sedlacek; Feng Zhang; Vitezslav Bryja; Orit Rozenblatt-Rosen; Naomi Habib; Aviv Regev; Maria K Lehtinen
Journal:  Cell       Date:  2021-04-30       Impact factor: 66.850

6.  c-MYC overexpression induces choroid plexus papillomas through a T-cell mediated inflammatory mechanism.

Authors:  Ashirwad Merve; Xinyu Zhang; Nicola Pomella; Serena Acquati; Joerg D Hoeck; Anaelle Dumas; Gabriel Rosser; Yichen Li; Jennie Jeyapalan; Silvia Vicenzi; Qianhai Fan; Zeng Jie Yang; Arianna Sabò; Denise Sheer; Axel Behrens; Silvia Marino
Journal:  Acta Neuropathol Commun       Date:  2019-05-29       Impact factor: 7.801

7.  Downregulation of ribosome biogenesis during early forebrain development.

Authors:  Kevin F Chau; Morgan L Shannon; Ryann M Fame; Erin Fonseca; Hillary Mullan; Matthew B Johnson; Anoop K Sendamarai; Mark W Springel; Benoit Laurent; Maria K Lehtinen
Journal:  Elife       Date:  2018-05-10       Impact factor: 8.140

Review 8.  Choroid plexus and the blood-cerebrospinal fluid barrier in disease.

Authors:  Peter Solár; Alemeh Zamani; Lucie Kubíčková; Petr Dubový; Marek Joukal
Journal:  Fluids Barriers CNS       Date:  2020-05-06

9.  Disruption of GMNC-MCIDAS multiciliogenesis program is critical in choroid plexus carcinoma development.

Authors:  Qun Li; Zhiyuan Han; Navleen Singh; Berta Terré; Ryann M Fame; Uzayr Arif; Thomas D Page; Tasneem Zahran; Ahmed Abdeltawab; Yuan Huang; Ping Cao; Jun Wang; Hao Lu; Hart G W Lidov; Kameswaran Surendran; Lizhao Wu; James Q Virga; Ying-Tao Zhao; Ulrich Schüller; Robert J Wechsler-Reya; Maria K Lehtinen; Sudipto Roy; Zhongmin Liu; Travis H Stracker; Haotian Zhao
Journal:  Cell Death Differ       Date:  2022-03-23       Impact factor: 12.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.